À retenir
In an online survey of 455 people, most of them with chronic conditions, perceptions of AI-enabled wearable health devices were largely positive, but technical failures, data accuracy and less human contact were significant concerns. The sample came from convenience and stratified sampling and the abstract gives no figures, so how common each view is remains unknown.
Study design
Étude transversale
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
AI-enabled wearables promise continuous monitoring, early detection and tailored care for chronic disease, but they only help if patients trust and use them. The authors surveyed how patients perceive, trust and know about these devices, to find what encourages or blocks adoption.
Population et méthode
Cross-sectional online questionnaire study of 455 participants, including individuals with chronic conditions, recruited by convenience and stratified sampling. The questionnaire covered demographics, Likert-scale items and multiple-choice questions on awareness of specific AI features and device functions. The abstract does not name the country or setting, or report percentages or statistical tests.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Perceptions were predominantly positive: most participants agreed wearables improve proactive care, enable remote consultations and give precise health insights.
- 2Significant concerns were technical failures, data accuracy and the possible reduction of human interaction.
- 3No notable demographic differences were identified, although participants with chronic conditions had more favourable views.
- 4The authors conclude that user education, technical reliability and professional oversight are needed for successful use of AI wearables in chronic disease.
Limites et incertitude
- 1Convenience sampling and an online survey favour people who are comfortable with technology, so views may be more positive than in the wider patient population.
- 2The abstract reports no percentages, effect sizes or P values, so the strength of the positive views and the concerns cannot be judged.
- 3Opinions about benefits are not evidence that the devices improve health, and the study did not measure real use or outcomes.
- 4The abstract does not say where the survey took place, so the findings may not generalise to other health systems.
Mise en perspective
The results suggest that people with chronic conditions are open to AI-supported wearables as long as they are reliable and sit alongside a clinician, which is a sensible stance. Before relying on a device for health decisions, check how well it has been validated and discuss any readings that worry you with your clinician.
Vos données
This is about attitudes toward wearables, not a measure to track. The concerns raised in the survey are practical ones for your own data: check for gaps or errors, use the same device consistently, and treat alerts as prompts to follow up with a professional, not as a diagnosis.
Comprendre ce type de preuve
Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Introduction
Wearable devices that incorporate artificial intelligence (AI) have revolutionised healthcare through continuous monitoring, early detection, and tailored management of chronic diseases.
Methods
This cross-sectional study analysed patients' perceptions, trust, and awareness of AI-driven wearable health technologies, emphasising the identification of primary facilitators and barriers to adoption. A total of 455 participants, comprising individuals with chronic conditions, were recruited through convenience and stratified sampling methods. Data were collected via an online questionnaire that included demographic questions, Likert-scale items, and multiple-choice questions to evaluate awareness of particular AI features and the functionalities of wearable devices.
Results and discussion
The findings indicated predominantly positive perceptions, with most participants concurring that wearable devices improve proactive care, facilitate remote consultations, and deliver precise health insights. Concerns regarding technical failures, data accuracy, and the potential reduction of human interaction were significant. No notable demographic differences were identified; however, participants with chronic conditions expressed more favourable perceptions. The research emphasises the necessity of user education, technical reliability, and professional oversight for the successful integration of AI-powered wearables in the management of chronic diseases.
Sources et attribution
Adoption barriers and facilitators of wearable health devices with AI integration: a patient-centred perspective.
Alzghaibi H.
Frontiers in medicine · 2025-04-03
DOI: 10.3389/fmed.2025.1557054 ↗PubMed · 40248075 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

